CJC 1295 (No DAC) + Ipamorelin
$70.00
For Research Use Only. Not for human or animal consumption. Not evaluated by the FDA.
This pairs two growth-hormone-pathway peptides: CJC-1295 without DAC (a short-acting GHRH analog, also known as Mod GRF 1-29) and Ipamorelin (a selective GH secretagogue). The combination is commonly studied together because the two compounds act on complementary receptor pathways.
Mechanism of Action
CJC-1295 (no DAC) stimulates GHRH receptors while Ipamorelin acts on ghrelin receptors — together prompting a larger, still-pulsatile growth hormone release than either compound produces alone.
Molecular Information
Research-context information only. For Research Use Only — not evaluated by the FDA, not intended to diagnose, treat, cure, or prevent any disease, and not for human or animal consumption.
